El Hospital Universitario Germans Trias i Pujol es un centro sanitario público ubicado al pie de la Sierra de la Marina, en el municipio de Badalona. Está construido sobre unos terrenos de propiedad municipal, que antiguamente eran una finca llamada Can Ruti, nombre como se conoce popularmente al hospital.

During the past decade, Hospital Universitari Germans Trias i Pujol conducted 463 clinical trials. In the 10-year time frame, 463 clinical trials started and 157 clinical trials were completed, i.e. on average, 33.9% percent of trials that started reached the finish line to date. In the past 5 years, 219 clinical trials started and 108 clinical trials were completed. i.e. 49.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitari Germans Trias i Pujol" #1 sponsor was "PETHEMA Foundation" with 52 trials, followed by "Germans Trias i Pujol Hospital" with 43 trials sponsored, "Pfizer" with 35 trials sponsored, "Celgene" with 34 trials sponsored and "Janssen Research & Development, LLC" with 34 trials sponsored. Other sponsors include 535 different institutions and companies that sponsored additional 277 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitari Germans Trias i Pujol" #1 collaborator was "Germans Trias i Pujol Hospital" with 25 trials as a collaborator, "Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia" with 20 trials as a collaborator, "Hospital Clinic of Barcelona" with 11 trials as a collaborator, "Merck Sharp & Dohme LLC" with 11 trials as a collaborator and "Bristol-Myers Squibb" with 10 trials as a collaborator. Other collaborators include 540 different institutions and companies that were collaborators in the rest 372 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitari Germans Trias i Pujol" are "HIV Infections" (44 trials), "Multiple Myeloma" (39 trials), "HIV" (18 trials), "Breast Cancer" (14 trials) and "COVID-19" (14 trials). Many other conditions were trialed in "Hospital Universitari Germans Trias i Pujol" in a lesser frequency.

Most popular intervention types in "Hospital Universitari Germans Trias i Pujol" are "Drug" (532 trials), "Other" (81 trials), "Biological" (54 trials), "Device" (45 trials) and "Procedure" (42 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (128 trials), "Dexamethasone" (32 trials), "Lenalidomide" (13 trials), "Prednisone" (13 trials) and "Rituximab" (13 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitari Germans Trias i Pujol" are 686 trials for "All" genders, 34 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are 213 active trials in "Hospital Universitari Germans Trias i Pujol". 4 are not yet recruiting, 115 are recruiting, 89 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 392 completed trials in Hospital Universitari Germans Trias i Pujol, 3 suspended trials, and 72 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitari Germans Trias i Pujol, 73 "Phase 1" clinical trials were conducted, 189 "Phase 2" clinical trials and 270 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 82 trials, and there were also 59 trials that are defined as “Not Applicable".